American Association for Clinical Chemistry
Better health through laboratory medicine
Emerging CV Risk Factors: Disclosures

 National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines Emerging Biomarkers for Primary Prevention of Cardiovascular Disease and Stroke 

These include all reported relationships within the previous 2 years that may be relevant to the guidelines document.

 

 

Grant

Other
Research Support

Speakers Bureau

Honoraria

Expert Witness

Ownership Interest

Consultant Advisory Board

Institution Employer

Other Disclosures

Myers

Significant (>$10K)/Other

None

None

None

None

None

None

None

None

None

Christenson

Significant (>$10K)/Other

Not reported

Siemens Medical Diagnostics

Not reported

Not reported

Not reported

Not reported

Siemens Medical Diagnositcs, Biosite Diagnostics, and Abbott Diagnostics

Not reported

Not reported

Cushman

Significant (>$10K)/Other

None

GlaxoSmithKline

None

None

None

None

GlaxoSmithKline

None

None

Grundy

Significant (>$10K)/Other

Pfizer

None

None

None

None

None

None

None

Merck, Merck/Schering- Plough, AstraZeneca,Pfizer, and GlaxoSmithKline

Ballantyne

Significant (>$10K)/Other

None

 

Abbott, AstraZeneca, GlaxoSmithKline, Merck,  Sanofi-Synthelabo, Schering-Plough, Takeda

AstraZeneca, GlaxoSmithKline, Merck, Merck/Schering-Plough, Pfizer, Schering-Plough

Abbott, AstraZeneca, GlaxoSmithKline, Merck, Merck/Schering-Plough, Novartis, Pfizer, Sanofi-Synthelabo, Schering-Plough, Takeda

None

None

Abbott, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, KOWA, Merck, Merck/Schering-Plough, Metabasis, Novartis, Pfizer, Sanofi-Synthelabo, Schering-Plough, Takeda

None

None

Cooper

Significant (>$10K)/Other

None

None

None

None

None

None

None

None

None

Labarthe

Significant (>$10K)/Other

None

None

None

None

None

None

None

None

None

Rifai

Significant (>$10K)/Other

None

None

None

None

None

None

None

None

Editor of Clinical Chemistry

Wilson

Significant (>$10K)/Other

None

None

None

 

None

 

None

 

None

None

 

None

 

None

 

Levy

Significant (>$10K)/Other

None

None

None

None

None

None

None

None

None